Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Güner Hayri Özsan
Dokuz Eylül University
51Publications
5H-index
96Citations
Publications 51
Newest
Published on Nov 1, 2018in British Journal of Haematology 5.21
Jan Walewski34
Estimated H-index: 34
(Curie Institute),
Andrzej Hellmann34
Estimated H-index: 34
(Gdańsk Medical University)
+ 12 AuthorsEwa Paszkiewicz-Kozik5
Estimated H-index: 5
(Curie Institute)
Published on Dec 7, 2017in Blood 16.56
Omur Gokmen Sevindik1
Estimated H-index: 1
(Fırat University),
Mustafa Pehlivan14
Estimated H-index: 14
(University of Gaziantep)
+ 20 AuthorsVildan Ozkocaman14
Estimated H-index: 14
(Uludağ University)
Introduction: Pomalidomide is a potent immunomodulatory drug (imid) with efficacy demonstrated in relapsed refractory multiple myeloma. In a phase 3 study, pomalidomide showed a benefit of PFS and OS over high dose dexamethasone, even in proteasome inhibitor and imid refractory patients. In our country, Pomalidomide has recently gained approval in relapsed refractory setting in patients who were both refractory to a proteasome inhibitor and an immunomodulatory drug. Before this approval we were ...
Published on Sep 30, 2017in Cukurova Medical Journal
Nurhilal Buyukkurt2
Estimated H-index: 2
,
Güner Hayri Özsan5
Estimated H-index: 5
+ 6 AuthorsBulent Undar11
Estimated H-index: 11
Amac: Bircok faktor hematopoetik kok hucre (HKH) engraftmanini etkiler. Bu calismada hematolojik kanseri olan hastalarda kemik iligindeki myelofibrozis ve anjiogenezisin engraftman uzerine etkisi arastirilmistir. Gerec ve Yontem: Otolog kok hucre nakli yapilan 34 hasta (20 erkek, 14 kadin) verileri degerlendirildi. Nakilden onceki son kemik iligindeki fibrozis 0-3 arasinda derecelendirildi, anjiogenezis stereolojik metod ile olculdu. Hastalar anjiogenezis parametrelerinin yogunluguna gore de iki...
Published on Oct 1, 2015in Clinical and Applied Thrombosis-Hemostasis 1.85
Abdullah Katgi4
Estimated H-index: 4
(Dokuz Eylül University),
Ömür Gökmen Sevindik3
Estimated H-index: 3
(Dokuz Eylül University)
+ 8 AuthorsYusuf Baran23
Estimated H-index: 23
(İzmir Institute of Technology)
Background:There have been concerns about the possible prothrombotic effects of nilotinib, especially in patients having cardiovascular risk factors. The potential mechanism behind the increased risk of thromboembolic events is still not clear.Objectives:In this study, we aimed to evaluate possible harmful effects of nilotinib on endothelial cells. To this aim, we examined proliferative capacity and secretory functions of healthy human carotid artery endothelial cells (HCtAECs) in response to ni...
Published on Sep 2, 2015in Leukemia & Lymphoma 2.67
Ömür Gökmen Sevindik3
Estimated H-index: 3
(Dokuz Eylül University),
Zeynep Gulsum Guc2
Estimated H-index: 2
(Dokuz Eylül University)
+ 9 AuthorsFatih Demirkan11
Estimated H-index: 11
(Dokuz Eylül University)
The serum albumin (SA) level has been reported to be an independent prognostic biomarker that may serve as a surrogate representative of disease biology in patients diagnosed with myelodysplastic syndrome (MDS). However, its prognostic ability has not been tested in a model adjusting for comorbidities. We analyzed 200 patients who were diagnosed as having de novo MDS. Median overall survival (OS) of all patients was 25 months and median leukemia-free survival (LFS) was 24 months. Median OS accor...
Published on Sep 1, 2015in Clinical Lymphoma, Myeloma & Leukemia 2.27
Ömür Gökmen Sevindik3
Estimated H-index: 3
(Dokuz Eylül University),
Inci Alacacioglu8
Estimated H-index: 8
(Dokuz Eylül University)
+ 8 AuthorsGüner Hayri Özsan5
Estimated H-index: 5
(Dokuz Eylül University)
e202 Methods: We present a series of 4 patients diagnosed with plasma cell leukemia (PCL) between 2009 and 2014. The LCP was diagnosed in these cytomorphology and by study of peripheral blood cytometry. 25% had LCP Primary BJ Lambda MM and 75% LPC Secondary. The therapeutic use in our patients was diverse and personalized; patients with Primary LPC receiving schemes with Bortezomib (25%) plus autologous stem cell transplantation and patients with Secundary LPC Dexamethasone alone (75%). Results:...
Published on Jun 1, 2015in Clinical Lymphoma, Myeloma & Leukemia 2.27
Ömür Gökmen Sevindik3
Estimated H-index: 3
(Dokuz Eylül University),
Sinan Mersin1
Estimated H-index: 1
(Dokuz Eylül University)
+ 9 AuthorsFatih Demirkan11
Estimated H-index: 11
(Dokuz Eylül University)
Abstract Introduction Essential thrombocythemia (ET) is the most common of the myeloproliferative neoplasms. For better predicting the occurrence of thrombotic events, an International Prognostic Score of Thrombosis for ET (IPSET-Thrombosis) was recently developed. We aimed to investigate the validity of IPSET-Thrombosis in a Turkish patient cohort and to compare the efficacy of IPSET-Thrombosis and conventional risk scoring systems in predicting thrombosis-free survival. Patients and Methods We...
123456